tiprankstipranks
Trending News
More News >

Phillip R Lynch Insider Profile

4 Followers
Phillip R Lynch, Director at Race Oncology Ltd., holds 340.00K shares in Island Pharmaceuticals Ltd (Ticker: AU:ILA), holds 450.61K shares in Race Oncology Ltd. (Ticker: AU:RAC).
tipranks
Phillip R Lynch

Phillip R Lynch
Race Oncology Ltd. (RAC)
Director

Ranked #14,344 out of 104,104 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+241.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$2M
91.07%
8.93%
A breakdown of Phillip R Lynch's holdings

Insider Roles

Race Oncology Ltd.
(RAC)
Director
Island Pharmaceuticals Ltd
(ILA)
Chairman
Roles that Phillip R Lynch holds in companies

Most Profitable Insider Trade

Stock:
Race Oncology Ltd.
(RAC)
Rating:Informative Buy
Date:Jun 29, 2020 - Jun 29, 2021
Return:+520.30%
The most profitable trade made by Phillip R Lynch

Phillip R Lynch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Race Oncology Ltd.
May 30, 2024
Director
Uninformative Buy
AU$1.49M
Island Pharmaceuticals Ltd
Mar 19, 2025
Chairman
Uninformative Sell
4.80K
AU$146.20K
List of latest transactions for each holding click on a transaction to see Phillip R Lynch's performance on stock

Phillip R Lynch insider profile FAQ

What is the percentage of profitable transactions made by Phillip R Lynch?
The percentage of profitable transactions made by Phillip R Lynch is 50%.
    What is the average return per transaction made by Phillip R Lynch?
    The average return per transaction made by Phillip R Lynch is 241.70%.
      What stocks does Phillip R Lynch hold?
      Phillip R Lynch holds: AU:RAC, AU:ILA stocks.
        What was Phillip R Lynch’s latest transaction?
        Phillip R Lynch latest transaction was an Uninformative Sell of AU$4.80K.
          What was Phillip R Lynch's most profitable transaction?
          Phillip R Lynch’s most profitable transaction was an Informative Buy of AU:RAC stock on June 29, 2020. The return on the trade was 520.30%.
            What is Phillip R Lynch's role in Race Oncology Ltd.?
            Phillip R Lynch's role in Race Oncology Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.